ACTINIUM PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $-1.6M | $5.5M |
| FY2014 | — | $-1.9M | $6.7M |
| FY2015 | — | $22.0M | $25.6M |
| FY2016 | — | $18.0M | $20.5M |
| FY2017 | — | $13.7M | $17.4M |
| FY2018 | — | $8.8M | $13.7M |
| FY2019 | — | $5.6M | $9.3M |
| FY2020 | — | $61.3M | $63.6M |
| FY2021 | — | $73.5M | $77.8M |
| FY2022 | — | $66.5M | $108.9M |